SCHEMBL7208901

SCHEMBL7208901

NCCCCCCCCNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H]1O[C@@H]1C(=O)O

nearest known ligand 0.60

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
CHRND Q07001 10/20 0.60
CHRNA1 P02708 6/20 0.60
CHRNG P07510 6/20 0.60
CHRNB1 P11230 6/20 0.60
GRIA1 P42261 5/20 0.54
CHRNB2 P17787 2/20 0.53
CHRNB4 P30926 2/20 0.53
CHRNA3 P32297 2/20 0.53
CHRNA4 P43681 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9091432 0.99 CHRNA1 (0.58) CHRNDCHRNA1CHRNGCHRNB1GRIA1
SCHEMBL240780 0.99 CHRNA1 (0.58) CHRNDCHRNA1CHRNGCHRNB1GRIA1
SCHEMBL9090677 0.99 CHRNA1 (0.58) CHRNDCHRNA1CHRNGCHRNB1GRIA1
SCHEMBL9089190 0.91 CAPN1 (0.49) CHRNDCHRNA1CHRNGCHRNB1GRIA1
SCHEMBL9089141 0.90 CHRND (0.61) CHRNDCHRNA1CHRNGCHRNB1GRIA1
SCHEMBL10632510 0.89 CHRNA1 (0.48) CHRNDCHRNA1CHRNGCHRNB1GRIA1
SCHEMBL14345716 0.87 CHRNB2 (0.67) CHRNDCHRNA1CHRNGCHRNB1GRIA1
SCHEMBL9088720 0.86 CAPN1 (0.53) CHRNDCHRNA1CHRNGCHRNB1GRIA1
SCHEMBL9090745 0.85 CHRNA1 (0.46) CHRNDCHRNA1CHRNGCHRNB1
SCHEMBL31607684 0.85 CAPN1 (0.68) CHRNDCHRNA1CHRNGCHRNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0921122-B1 EPOXYSUCCINAMIDE DERIVATIVES OR SALTS THEREOF TAIHO PHARMACEUTICAL CO LTD (JP) 2003-05-21 EP disclosed
EP-0808839-B1 EPOXYSUCCINAMIDE DERIVATIVES OR SALTS THEREOF, AND DRUGS CONTAINING THE SAME TAIHO PHARMACEUTICAL CO LTD (JP) 2001-05-23 EP disclosed
US-6110967-A USEFUL AS AGENTS FOR PREVENTING AND TREATING METABOLIC OSTEOPATHY SUCH AS OSTEOPOROSIS, HYPERCALCEMIA AND BONE METASTASIS OF CANCER BECAUSE THEY SPECIFICALLY INHIBITS CATHEPSIN L AND ITS FAMILY ENZYMES TO INHIBIT BONE RESORPTION TAIHO PHARMACEUTICALS CO., LTD. (JP) 2000-08-29 US disclosed
US-5883121-A INHIBITING ACTIVITY AGAINST CATHEPSIN, AND IS USEFUL FOR PREVENTION AND TREATMENT OF OSTEOPATHY SUCH AS OSTEOPOROSIS TAIHO PHARMACEUTICAL CO., LTD. (JP) 1999-03-16 US disclosed
EP-0808839-A1 EPOXYSUCCINAMIDE DERIVATIVES OR SALTS THEREOF, AND DRUGS CONTAINING THE SAME TAIHO PHARMACEUTICAL CO., LTD. (JP) 1997-11-26 EP disclosed
EP-0655447-A1 Epoxysuccinic acid derivatives Takeda Chemical Industries, Ltd. (JP) 1995-05-31 EP disclosed